Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 856 AL 870

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody

Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, Lannfelt L, Bradley H, Rabe M, Koyama A, Reyderman L, Berry DA, Berry S, Gordon R, Kramer LD, Cummings JL.

Alzheimers Res Ther. 2021 Apr 17;13(1):80. doi: 10.1186/s13195-021-00813-8.

Prospects of Saffron and its Derivatives in Alzheimer's Disease

Zandi N, Pazoki B, Momeni Roudsari N, Lashgari NA, Jamshidi V, Momtaz S, Abdolghaffari AH, Akhondzadeh S.

Arch Iran Med. 2021 Mar 1;24(3):233-252. doi: 10.34172/aim.2021.35.

Adapting Alzheimer Disease and Related Dementias Clinical Research Evaluations in the Age of COVID-19

Loizos M, Neugroschl J, Zhu CW, Li C, Sewell M, Kinsella MT, Aloysi A, Grossman H, Schimming C, Martin J, Sano M.

Alzheimer Dis Assoc Disord. 2021 Apr-Jun 01;35(2):172-177. doi: 10.1097/WAD.0000000000000455.

Atypical antipsychotics in the treatment of psychotic symptoms in Alzheimer's disease: a systematic review

Vinaşi R, Buciuta A, Coman HG.

Int Clin Psychopharmacol. 2021 Jul 1;36(4):169-180. doi: 10.1097/YIC.0000000000000358.

The Effects of Long-term Medication Use in Alzheimer Disease

Karceski S.

Neurology. 2021 Apr 27;96(17):e2247-e2250. doi: 10.1212/WNL.0000000000011843.

The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer's Disease

Xia Q, Yang X, Shi J, Liu Z, Peng Y, Wang W, Li B, Zhao Y, Xiao J, Huang L, Wang D, Gao X.

Mol Neurobiol. 2021 Aug;58(8):4038-4050. doi: 10.1007/s12035-021-02385-y. Epub 2021 Apr 29.

Update on neuroimaging in Alzheimer's disease

Sintini I, Whitwell JL.

Curr Opin Neurol. 2021 Aug 1;34(4):525-531. doi: 10.1097/WCO.0000000000000947.

Interventional Study to Evaluate the Clinical Effects and Safety of the Nutraceutical Compound BrainUp-10® in a Cohort of Patients with Alzheimer's Disease: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial

Guzman-Martinez L, Farías GA, Tapia JP, Sánchez MP, Fuentes P, Gloger S, Maccioni RB.

J Alzheimers Dis. 2021;81(3):1231-1241. doi: 10.3233/JAD-201501.

Leveraging hallmark Alzheimer's molecular targets using phytoconstituents: Current perspective and emerging trends

Dhage PA, Sharbidre AA, Dakua SP, Balakrishnan S.

Biomed Pharmacother. 2021 Jul;139:111634. doi: 10.1016/j.biopha.2021.111634. Epub 2021 May 6.

Safety and Tolerability of GRF6019 Infusions in Severe Alzheimer's Disease: A Phase II Double-Blind Placebo-Controlled Trial

Hannestad J, Duclos T, Chao W, Koborsi K, Klutzaritz V, Beck B, Patel AK, Scott J, Thein SG, Cummings JL, Kay G, Braithwaite S, Nikolich K.

J Alzheimers Dis. 2021;81(4):1649-1662. doi: 10.3233/JAD-210011.

Individualized Prediction of Early Alzheimer's Disease Based on Magnetic Resonance Imaging Radiomics, Clinical, and Laboratory Examinations: A 60-Month Follow-Up Study

Tang L, Wu X, Liu H, Wu F, Song R, Zhang W, Guo D, Feng J, Li C.

J Magn Reson Imaging. 2021 Nov;54(5):1647-1657. doi: 10.1002/jmri.27689. Epub 2021 May 13.

Does the application of acetylcholinesterase inhibitors in the treatment of Alzheimer's disease lead to depression?

Mitić M, Lazarević-Pašti T.

Expert Opin Drug Metab Toxicol. 2021 Jul;17(7):841-856. doi: 10.1080/17425255.2021.1931681. Epub 2021 Jun 10.

MADRID+90 study on factors associated with longevity: Study design and preliminary data

Fernández-Blázquez MA, Del Ser T, Frades-Payo B, Ávila-Villanueva M, Valentí-Soler M, Benítez-Robredo MT, Bermejo-Aguña A, Pedrero-Pérez EJ, Quilis-Sancho J, Pastor AB, Fernández-Garrido C, Morales-Alonso S, Diaz-Olalla JM, Santos NC, Maestú F, Gómez-Ramírez J.

PLoS One. 2021 May 17;16(5):e0251796. doi: 10.1371/journal.pone.0251796. eCollection 2021.

New IDEAS Amyloid Imaging 2021 Study: Running in Place with Ineffective Anti-Amyloid Treatments for Alzheimer's Disease Patients

Barrio JR, Whitehouse P, Alavi A, Høilund-Carlsen PF.

J Alzheimers Dis. 2021;82(2):461-462. doi: 10.3233/JAD-210383.

Benefits in Alzheimer's Disease of Sensory and Multisensory Stimulation

Yang H, Luo Y, Hu Q, Tian X, Wen H.

J Alzheimers Dis. 2021;82(2):463-484. doi: 10.3233/JAD-201554.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias